References

The page below is a sample from the LabCE course HER2 Testing in Breast Cancer. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about HER2 Testing in Breast Cancer (online CE course)
References

Ahn S, Woo JW, Lee K, Park SY. HER2 Status in Breast Cancer: Changes in Guidelines and Complicating Factors for Interpretation. Journal of Pathology and Translational Medicine 2020; 54: 34-44. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986968/pdf/jptm-2019-11-03.pdfAccessed November 13, 2022.
ASCO–CAP HER2 Test Guideline Recommendations: Summary of Guideline 2007, 2013and 2018. Recommendations. College of American Pathologists (CAP) website. Available at: https://documents.cap.org/documents/asco-cap-her2-recommendations.pdf. Accessed September 30, 2022.
Breast cancer diagnostics. Ventana Medical Systems Web site. Available at: http://www.ventana.com/breast. Accessed November 13, 2022.
CAP Commission on Laboratory Accreditation- Laboratory Accreditation Program. Anatomic Pathology Checklist. Northfield, IL: College of American Pathologists; September 2021.
Hassan O. What Breast Medical Oncologists Need From Pathologists. March 20, 2019. Retrieved from Medscape. Available at https://emedicine.medscape.com/article/1668113-overview#a1 Accessed November 13, 2022.
HercepTest™ for Dako Autostainer. Agilent Web site. Available at: https://www.agilent.com/cs/library/packageinsert/public/PD04084US_03.pdf Accessed November 13, 2022.
Invitrogen™ [package insert]. Carmarillo, CA. Invitrogen Corporation; 2008.
Menard S, Tagliabue E, Campliglio M, and Pupa SM. Role of HER2 Gene Overexpression in Breast Carcinoma. Retrieved from PubMed at https://pubmed.ncbi.nlm.nih.gov/10623878/. Accessed on November 13, 2022.
PathVysion. Abbott Molecular Website. Available at: http://www.abbottmolecular.com/us/products/oncology/fish/breast-cancer-pathvysion-her2.html. Accessed September 30, 2022.
Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. J Clin Oncol [online]. 2013. Available at: http://jco.ascopubs.org/content/31/31/3997.full. Accessed September 30, 2022.
Xiaohong PU, Jiong SH, Zhiwen LI, Anning FE, Qing YE. Comparison of the 2007 and 2013 ASCO/CAP evaluation systems for HER2 amplification in breast cancer. Pathol - Research & Practice. June 2015;211(6): 421-425. Available at: http://www.sciencedirect.com/science/article/pii/S0344033814002751. Accessed September 22, 2022.